Steve Hibbert

机构：University College London

发表论文 13 篇 · 总被引 2055 次 · h-index 10

代表论文

• Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial (2017 · The Lancet · 被引 885)
• Risk of Cardiac Arrhythmias During Hypoglycemia in Patients With Type 2 Diabetes and Cardiovascular Risk (2014 · Diabetes · 被引 406)
• Diagnostic accuracy of magnetic resonance enterography and small bowel ultrasound for the extent and activity of newly diagnosed and relapsed Crohn's disease (METRIC): a multicentre trial (2018 · ˜The œLancet. Gastroenterology & hepatology · 被引 269)
• Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial (2025 · The Lancet · 被引 149)
• Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson’s disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The ‘Exenatide-PD3’ study (2021 · BMJ Open · 被引 85)
• What Effects Might Exenatide have on Non-Motor Symptoms in Parkinson’s Disease: A Post Hoc Analysis (2018 · Journal of Parkinson s Disease · 被引 79)